T

Tong Ren Tang Technologies Co Ltd
HKEX:1666

Watchlist Manager
Tong Ren Tang Technologies Co Ltd
HKEX:1666
Watchlist
Price: 5.13 HKD 1.79% Market Closed
Market Cap: 6.6B HKD
Have any thoughts about
Tong Ren Tang Technologies Co Ltd?
Write Note

Tong Ren Tang Technologies Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tong Ren Tang Technologies Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
T
Tong Ren Tang Technologies Co Ltd
HKEX:1666
Cash from Financing Activities
ÂĄ292.1m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-ÂĄ753.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-ÂĄ2.1B
CAGR 3-Years
-48%
CAGR 5-Years
-52%
CAGR 10-Years
-26%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-ÂĄ1.6B
CAGR 3-Years
-84%
CAGR 5-Years
-15%
CAGR 10-Years
-105%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-ÂĄ3.4B
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
-24%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Financing Activities
ÂĄ90.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tong Ren Tang Technologies Co Ltd
Glance View

Market Cap
6.6B HKD
Industry
Pharmaceuticals

Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. The company is headquartered in Beijing, Beijing. The company went IPO on 2000-10-31. The Company’s subsidiaries include Beijing Tong Ren Tang Technologies (Tangshan) Co., Ltd, Beijing Tong Ren Tang Century Advertising Co., Limited and Beijing Tong Ren Tang International Natural-Pharm Co., Ltd.. Through its subsidiaries, the Company is also engaged in cultivating, purchasing and selling Chinese medicinal raw materials.

Intrinsic Value
8.26 HKD
Undervaluation 38%
Intrinsic Value
Price
T

See Also

What is Tong Ren Tang Technologies Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
292.1m CNY

Based on the financial report for Jun 30, 2024, Tong Ren Tang Technologies Co Ltd's Cash from Financing Activities amounts to 292.1m CNY.

What is Tong Ren Tang Technologies Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-11%

The average annual Cash from Financing Activities growth rates for Tong Ren Tang Technologies Co Ltd have been -11% over the past three years .

Back to Top